Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	48	non-cytoplasmic
49	71	transmembrane
72	80	cytoplasmic
81	104	transmembrane
105	105	non-cytoplasmic
106	130	transmembrane
131	140	cytoplasmic
141	162	transmembrane
163	167	non-cytoplasmic
168	188	transmembrane
189	232	cytoplasmic
233	254	transmembrane
255	269	non-cytoplasmic
270	289	transmembrane
290	299	cytoplasmic
300	318	transmembrane
319	323	non-cytoplasmic
324	347	transmembrane
348	356	cytoplasmic
357	379	transmembrane
380	390	non-cytoplasmic
391	410	transmembrane
411	432	cytoplasmic

Input:
>Pf6N2E2_628 2-ketogluconate transporter
MQTLNLATRRWWYIMPIVFITYSLAYLDRANYGFAAASGMAKDLMITPGLSSLLGALFFL
GYFFFQVPGAIYAQKHSVKKLIFVSLILWGSLATLTGVVSNAYWLIVIRFMLGVVEAAVM
PAMLVYLCHWFTRAERSRANTFLILGNPVTMLWMSVVSGYLVQQFDWRWMFIIEGLPAVL
WAFIWWRLADDRPSQAKWLSDQEKHDLESALAAEQVGIKAVKNYAEAFRSPKVIILALQF
FCWSIGVYGFVLWLPSILKAGLQMNMVEAGWLSSLPYLAAVIGMLVVSWASDKAQKRKRF
VWPPLLVASIAFYASYLLGPEHFWWSYSLLVVAGACMYAPYGPFFAIVPEILPANVAGGA
MALINSMGALGSFGGSYLVGYLNGSTGSPGMSFLLMSGALLVAVVLTLALKPGASDRVLS
KTATPHSAPAHS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server